APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Pathology Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Pathology Software Market Outlook and Growth Opportunities 2026

12 August 2026190 pages

Choose your research edition.

Industry ResearchAI Pathology Software Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Pathology Software Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal AI Pathology Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Pathology Software Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Pathology Software Market Analysis and Forecast 2026-2032175 pages · $4,950 USD

Market perspective

The global AI Pathology Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Pathology Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Pathology Software market include Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, Visiopharm A/S and Tempus AI, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Pathology Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Pathology Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Pathology Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Pathology Software market.

AI Pathology Software Segment by Company

Aiforia Technologies Plc

Ibex Medical Analytics Ltd.

Proscia Inc.

Philips

Roche Diagnostics International Ltd

Leica Biosystems Nussloch GmbH

Fujifilm Holdings Corporation

Visiopharm A/S

Tempus AI, Inc.

Yitu Technology Co., Ltd.

Deepwise Healthcare Technology Co., Ltd.

PathAI, Inc.

Paige AI, Inc.

Indica Labs

AI Pathology Software Segment by Type

Histopathology AI Analysis Software

Cytopathology AI Analysis Software

Immunohistochemistry AI Analysis Software

Molecular Pathology AI Analysis Software

AI Pathology Software Segment by Application

Hospital Pathology Department

Third-party Medical Testing Laboratory

Pharmaceutical R&D

AI Pathology Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Pathology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Pathology Software key companies, revenue, market share, and recent developments.

3. To split the AI Pathology Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Pathology Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Pathology Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Pathology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Pathology Software industry.

Chapter 3: Detailed analysis of AI Pathology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Pathology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Pathology Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Pathology Software Industry Trends Table 2. AI Pathology Software Industry Drivers Table 3. AI Pathology Software Industry Opportunities and Challenges Table 4. AI Pathology Software Industry Restraints Table 5. Global AI Pathology Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Pathology Software Revenue Share by Company (2021-2026) Table 7. Global AI Pathology Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Pathology Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Pathology Software Company, Product Type & Application Table 10. Global AI Pathology Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Pathology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Histopathology AI Analysis Software Table 15. Significant Companies of Cytopathology AI Analysis Software Table 16. Significant Companies of Immunohistochemistry AI Analysis Software Table 17. Significant Companies of Molecular Pathology AI Analysis Software Table 18. Global AI Pathology Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI Pathology Software Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI Pathology Software Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI Pathology Software Sales Value Share by Type (2021-2026) Table 22. Global AI Pathology Software Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Pathology Department Table 24. Significant Companies of Third-party Medical Testing Laboratory Table 25. Significant Companies of Pharmaceutical R&D Table 26. Global AI Pathology Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Pathology Software Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI Pathology Software Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI Pathology Software Sales Value Share by Application (2021-2026) Table 30. Global AI Pathology Software Sales Value Share by Application (2027-2032) Table 31. Global AI Pathology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Pathology Software Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI Pathology Software Sales Value Share by Region (2021-2026) Table 34. Global AI Pathology Software Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI Pathology Software Sales Value Share by Region (2027-2032) Table 36. Global AI Pathology Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Pathology Software Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI Pathology Software Sales Value Market Share by Country (2021-2026) Table 39. Global AI Pathology Software Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI Pathology Software Sales Value Market Share by Country (2027-2032) Table 41. Aiforia Technologies Plc Company Information Table 42. Aiforia Technologies Plc Business Overview Table 43. Aiforia Technologies Plc AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Aiforia Technologies Plc AI Pathology Software Product Portfolio Table 45. Aiforia Technologies Plc Recent Development Table 46. Ibex Medical Analytics Ltd. Company Information Table 47. Ibex Medical Analytics Ltd. Business Overview Table 48. Ibex Medical Analytics Ltd. AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Ibex Medical Analytics Ltd. AI Pathology Software Product Portfolio Table 50. Ibex Medical Analytics Ltd. Recent Development Table 51. Proscia Inc. Company Information Table 52. Proscia Inc. Business Overview Table 53. Proscia Inc. AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Proscia Inc. AI Pathology Software Product Portfolio Table 55. Proscia Inc. Recent Development Table 56. Philips Company Information Table 57. Philips Business Overview Table 58. Philips AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Philips AI Pathology Software Product Portfolio Table 60. Philips Recent Development Table 61. Roche Diagnostics International Ltd Company Information Table 62. Roche Diagnostics International Ltd Business Overview Table 63. Roche Diagnostics International Ltd AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Roche Diagnostics International Ltd AI Pathology Software Product Portfolio Table 65. Roche Diagnostics International Ltd Recent Development Table 66. Leica Biosystems Nussloch GmbH Company Information Table 67. Leica Biosystems Nussloch GmbH Business Overview Table 68. Leica Biosystems Nussloch GmbH AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Leica Biosystems Nussloch GmbH AI Pathology Software Product Portfolio Table 70. Leica Biosystems Nussloch GmbH Recent Development Table 71. Fujifilm Holdings Corporation Company Information Table 72. Fujifilm Holdings Corporation Business Overview Table 73. Fujifilm Holdings Corporation AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Fujifilm Holdings Corporation AI Pathology Software Product Portfolio Table 75. Fujifilm Holdings Corporation Recent Development Table 76. Visiopharm A/S Company Information Table 77. Visiopharm A/S Business Overview Table 78. Visiopharm A/S AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Visiopharm A/S AI Pathology Software Product Portfolio Table 80. Visiopharm A/S Recent Development Table 81. Tempus AI, Inc. Company Information Table 82. Tempus AI, Inc. Business Overview Table 83. Tempus AI, Inc. AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Tempus AI, Inc. AI Pathology Software Product Portfolio Table 85. Tempus AI, Inc. Recent Development Table 86. Yitu Technology Co., Ltd. Company Information Table 87. Yitu Technology Co., Ltd. Business Overview Table 88. Yitu Technology Co., Ltd. AI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Yitu Technology Co., Ltd. AI Pathology Software Product Portfolio Table 90. Yitu Technology Co., Ltd. Recent Development Table 91. Deepwise Healthcare Technology Co., Ltd. Company Information Table 92. Deepwise Healthcare Technology Co., Ltd. Business Overview Table 93. Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product Portfolio Table 95. Deepwise Healthcare Technology Co., Ltd. Recent Development Table 96. PathAI, Inc. Company Information Table 97. PathAI, Inc. Business Overview Table 98. PathAI, Inc. AI Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. PathAI, Inc. AI Pathology Software Product Portfolio Table 100. PathAI, Inc. Recent Development Table 101. Paige AI, Inc. Company Information Table 102. Paige AI, Inc. Business Overview Table 103. Paige AI, Inc. AI Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Paige AI, Inc. AI Pathology Software Product Portfolio Table 105. Paige AI, Inc. Recent Development Table 106. Indica Labs Company Information Table 107. Indica Labs Business Overview Table 108. Indica Labs AI Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Indica Labs AI Pathology Software Product Portfolio Table 110. Indica Labs Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. AI Pathology Software Product Image Figure 2. Global AI Pathology Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Pathology Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Pathology Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Histopathology AI Analysis Software Image Figure 8. Cytopathology AI Analysis Software Image Figure 9. Immunohistochemistry AI Analysis Software Image Figure 10. Molecular Pathology AI Analysis Software Image Figure 11. Global AI Pathology Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI Pathology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI Pathology Software Sales Value Share by Type (2021-2032) Figure 14. Hospital Pathology Department Image Figure 15. Third-party Medical Testing Laboratory Image Figure 16. Pharmaceutical R&D Image Figure 17. Global AI Pathology Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Pathology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI Pathology Software Sales Value Share by Application (2021-2032) Figure 20. Global AI Pathology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI Pathology Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Histopathology AI Analysis Software
  • Cytopathology AI Analysis Software
  • Immunohistochemistry AI Analysis Software
  • Molecular Pathology AI Analysis Software
Applications
  • Hospital Pathology Department
  • Third-party Medical Testing Laboratory
  • Pharmaceutical R&D
Companies covered
  • Aiforia Technologies Plc
  • Ibex Medical Analytics Ltd.
  • Proscia Inc.
  • Philips
  • Roche Diagnostics International Ltd
  • Leica Biosystems Nussloch GmbH
  • Fujifilm Holdings Corporation
  • Visiopharm A/S
  • Tempus AI, Inc.
  • Yitu Technology Co., Ltd.
  • Deepwise Healthcare Technology Co., Ltd.
  • PathAI, Inc.
  • Paige AI, Inc.
  • Indica Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Pathology Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Pathology Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Pathology Software Market Dynamics
  1. 2.1 AI Pathology Software Industry Trends
  2. 2.2 AI Pathology Software Industry Drivers
  3. 2.3 AI Pathology Software Industry Opportunities and Challenges
  4. 2.4 AI Pathology Software Industry Restraints
3 AI Pathology Software Market by Company
  1. 3.1 Global AI Pathology Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Pathology Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Pathology Software Company Ranking (2024-2026)
  4. 3.4 Global AI Pathology Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Pathology Software Company Product Type and Application
  6. 3.6 Global AI Pathology Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Pathology Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Pathology Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Pathology Software Market by Type
  1. 4.1 AI Pathology Software Type Introduction
  2. 4.1.1 Histopathology AI Analysis Software
  3. 4.1.2 Cytopathology AI Analysis Software
  4. 4.1.3 Immunohistochemistry AI Analysis Software
  5. 4.1.4 Molecular Pathology AI Analysis Software
  6. 4.2 Global AI Pathology Software Sales Value by Type
  7. 4.2.1 Global AI Pathology Software Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI Pathology Software Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI Pathology Software Sales Value Share by Type (2021-2032)
5 AI Pathology Software Market by Application
  1. 5.1 AI Pathology Software Application Introduction
  2. 5.1.1 Hospital Pathology Department
  3. 5.1.2 Third-party Medical Testing Laboratory
  4. 5.1.3 Pharmaceutical R&D
  5. 5.2 Global AI Pathology Software Sales Value by Application
  6. 5.2.1 Global AI Pathology Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI Pathology Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI Pathology Software Sales Value Share by Application (2021-2032)
6 AI Pathology Software Regional Value Analysis
  1. 6.1 Global AI Pathology Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Pathology Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Pathology Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Pathology Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Pathology Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Pathology Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Pathology Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Pathology Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Pathology Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Pathology Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Pathology Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Pathology Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Pathology Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Pathology Software Sales Value Share by Country, 2025 VS 2032
7 AI Pathology Software Country-level Value Analysis
  1. 7.1 Global AI Pathology Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Pathology Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Pathology Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Pathology Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Pathology Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Pathology Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Pathology Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Pathology Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Pathology Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Pathology Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Pathology Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Pathology Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Pathology Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Pathology Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Pathology Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Pathology Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Pathology Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Pathology Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Pathology Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Pathology Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Pathology Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Pathology Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Pathology Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Pathology Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Pathology Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Pathology Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Pathology Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Pathology Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Pathology Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Pathology Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Pathology Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Pathology Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Pathology Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Pathology Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Pathology Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aiforia Technologies Plc
  2. 8.1.1 Aiforia Technologies Plc Company Information
  3. 8.1.2 Aiforia Technologies Plc Business Overview
  4. 8.1.3 Aiforia Technologies Plc AI Pathology Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aiforia Technologies Plc AI Pathology Software Product Portfolio
  6. 8.1.5 Aiforia Technologies Plc Recent Developments
  7. 8.2 Ibex Medical Analytics Ltd.
  8. 8.2.1 Ibex Medical Analytics Ltd. Company Information
  9. 8.2.2 Ibex Medical Analytics Ltd. Business Overview
  10. 8.2.3 Ibex Medical Analytics Ltd. AI Pathology Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ibex Medical Analytics Ltd. AI Pathology Software Product Portfolio
  12. 8.2.5 Ibex Medical Analytics Ltd. Recent Developments
  13. 8.3 Proscia Inc.
  14. 8.3.1 Proscia Inc. Company Information
  15. 8.3.2 Proscia Inc. Business Overview
  16. 8.3.3 Proscia Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Proscia Inc. AI Pathology Software Product Portfolio
  18. 8.3.5 Proscia Inc. Recent Developments
  19. 8.4 Philips
  20. 8.4.1 Philips Company Information
  21. 8.4.2 Philips Business Overview
  22. 8.4.3 Philips AI Pathology Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Philips AI Pathology Software Product Portfolio
  24. 8.4.5 Philips Recent Developments
  25. 8.5 Roche Diagnostics International Ltd
  26. 8.5.1 Roche Diagnostics International Ltd Company Information
  27. 8.5.2 Roche Diagnostics International Ltd Business Overview
  28. 8.5.3 Roche Diagnostics International Ltd AI Pathology Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Diagnostics International Ltd AI Pathology Software Product Portfolio
  30. 8.5.5 Roche Diagnostics International Ltd Recent Developments
  31. 8.6 Leica Biosystems Nussloch GmbH
  32. 8.6.1 Leica Biosystems Nussloch GmbH Company Information
  33. 8.6.2 Leica Biosystems Nussloch GmbH Business Overview
  34. 8.6.3 Leica Biosystems Nussloch GmbH AI Pathology Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Leica Biosystems Nussloch GmbH AI Pathology Software Product Portfolio
  36. 8.6.5 Leica Biosystems Nussloch GmbH Recent Developments
  37. 8.7 Fujifilm Holdings Corporation
  38. 8.7.1 Fujifilm Holdings Corporation Company Information
  39. 8.7.2 Fujifilm Holdings Corporation Business Overview
  40. 8.7.3 Fujifilm Holdings Corporation AI Pathology Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fujifilm Holdings Corporation AI Pathology Software Product Portfolio
  42. 8.7.5 Fujifilm Holdings Corporation Recent Developments
  43. 8.8 Visiopharm A/S
  44. 8.8.1 Visiopharm A/S Company Information
  45. 8.8.2 Visiopharm A/S Business Overview
  46. 8.8.3 Visiopharm A/S AI Pathology Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Visiopharm A/S AI Pathology Software Product Portfolio
  48. 8.8.5 Visiopharm A/S Recent Developments
  49. 8.9 Tempus AI, Inc.
  50. 8.9.1 Tempus AI, Inc. Company Information
  51. 8.9.2 Tempus AI, Inc. Business Overview
  52. 8.9.3 Tempus AI, Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tempus AI, Inc. AI Pathology Software Product Portfolio
  54. 8.9.5 Tempus AI, Inc. Recent Developments
  55. 8.10 Yitu Technology Co., Ltd.
  56. 8.10.1 Yitu Technology Co., Ltd. Company Information
  57. 8.10.2 Yitu Technology Co., Ltd. Business Overview
  58. 8.10.3 Yitu Technology Co., Ltd. AI Pathology Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yitu Technology Co., Ltd. AI Pathology Software Product Portfolio
  60. 8.10.5 Yitu Technology Co., Ltd. Recent Developments
  61. 8.11 Deepwise Healthcare Technology Co., Ltd.
  62. 8.11.1 Deepwise Healthcare Technology Co., Ltd. Company Information
  63. 8.11.2 Deepwise Healthcare Technology Co., Ltd. Business Overview
  64. 8.11.3 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product Portfolio
  66. 8.11.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments
  67. 8.12 PathAI, Inc.
  68. 8.12.1 PathAI, Inc. Company Information
  69. 8.12.2 PathAI, Inc. Business Overview
  70. 8.12.3 PathAI, Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PathAI, Inc. AI Pathology Software Product Portfolio
  72. 8.12.5 PathAI, Inc. Recent Developments
  73. 8.13 Paige AI, Inc.
  74. 8.13.1 Paige AI, Inc. Company Information
  75. 8.13.2 Paige AI, Inc. Business Overview
  76. 8.13.3 Paige AI, Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Paige AI, Inc. AI Pathology Software Product Portfolio
  78. 8.13.5 Paige AI, Inc. Recent Developments
  79. 8.14 Indica Labs
  80. 8.14.1 Indica Labs Company Information
  81. 8.14.2 Indica Labs Business Overview
  82. 8.14.3 Indica Labs AI Pathology Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Indica Labs AI Pathology Software Product Portfolio
  84. 8.14.5 Indica Labs Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst